Radioimmunotherapy of non Hodgkins lymphomas.
Academic Article
Overview
abstract
Radioimmunotherapy of lymphoma has shown encouraging responses and is already approved for therapy of B-cell NHL. On going trials to further optimize delivery of higher doses of labeled antibodies are promising and suggest that other reagents may soon be available to target NHL.
